These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31404322)

  • 1. Hepatocellular carcinoma grading and recurrence prediction using T
    Qin X; Yang T; Huang Z; Long L; Zhou Z; Li W; Gao Y; Wang M; Zhang X
    Oncol Lett; 2019 Sep; 18(3):2322-2329. PubMed ID: 31404322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combination of Gd-EOB-DTPA Enhanced T1 Mapping with Apparent Diffusion Coefficient could Improve the Diagnostic Efficacy of Hepatocellular Carcinoma Grading.
    He H; Li X; Liu J; Tong Q; Ling M; Zeng Z; Zhou Z
    Curr Med Imaging; 2024; 20(1):e15734056259418. PubMed ID: 38918998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma.
    Peng Z; Jiang M; Cai H; Chan T; Dong Z; Luo Y; Li ZP; Feng ST
    BMC Cancer; 2016 Aug; 16():625. PubMed ID: 27520833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].
    Hu MJ; Yu YX; Fan YF; Jiang YM; Hu S; Wang XM; Hu CH
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1299-1304. PubMed ID: 32375436
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.
    Wang F; Numata K; Okada M; Chuma M; Nihonmatsu H; Moriya S; Nozaki A; Ogushi K; Luo W; Ruan L; Nakano M; Otani M; Inayama Y; Maeda S
    Quant Imaging Med Surg; 2021 Jun; 11(6):2521-2540. PubMed ID: 34079721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T
    Yang L; Ding Y; Rao S; Chen C; Zeng M
    J Magn Reson Imaging; 2021 Mar; 53(3):896-902. PubMed ID: 32979019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma.
    Mao Y; Wang J; Zhu Y; Chen J; Mao L; Kong W; Qiu Y; Wu X; Guan Y; He J
    Hepatobiliary Surg Nutr; 2022 Feb; 11(1):13-24. PubMed ID: 35284527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma.
    Chen Y; Qin X; Long L; Zhang L; Huang Z; Jiang Z; Li C
    J Magn Reson Imaging; 2020 Jun; 51(6):1755-1763. PubMed ID: 31675163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study.
    Zhao QY; Liu SS; Fan MX
    J Gastrointest Oncol; 2022 Apr; 13(2):792-801. PubMed ID: 35557582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging and diffusion-weighted MR imaging in predicting microvascular invasion in hepatocellular carcinoma and the prognostic significance].
    Zhu YJ; Feng B; Wang BZ; Wang S; Ye F; Ma XH; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):312-317. PubMed ID: 33752311
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary clinical study of the safety of hepatectomy predicted by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced T1 mapping magnetic resonance imaging.
    Liu J; Li Q; Shi N; Chen Y; Li Y; Zhang M; Huang Y
    JGH Open; 2021 Mar; 5(3):382-389. PubMed ID: 33732886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping.
    Liu Z; Yang S; Chen X; Luo C; Feng J; Chen H; Ouyang F; Zhang R; Li X; Liu W; Guo B; Hu Q
    Front Oncol; 2022; 12():954445. PubMed ID: 36313692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma.
    Wang F; Numata K; Chuma M; Nihonmatsu H; Moriya S; Nozaki A; Ogushi K; Fukuda H; Okada M; Ruan L; Luo W; Koizumi N; Nakano M; Otani M; Inayama Y; Maeda S
    Abdom Radiol (NY); 2021 Jun; 46(6):2527-2539. PubMed ID: 33388895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.
    Schelhorn J; Best J; Dechêne A; Göbel T; Bertram S; Lauenstein T; Kinner S
    Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.